Curonix Announces Published PNS IMPACT Clinical Study Showing Freedom® Peripheral Nerve Stimulator (PNS) System is Associated with Reductions in Pain Scores, Opioid Use and Overall Patient Burden

Data ReadoutpositiveFreedom® Peripheral Nerve Stimulator (PNS) SystemPositive

AI Analysis

Summary

Curonix announced publication of the PNS IMPACT clinical study demonstrating that its Freedom Peripheral Nerve Stimulator System reduced pain scores, opioid use, and overall patient burden.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

PNS IMPACT Clinical Study showed reductions in pain scores, opioid use and overall patient burden

Importance:5/10

Sentiment:

0.70

clinical trialdata readoutperipheral nerve stimulationpain managementopioid reduction

Related Companies

$IBO

Read the original article

Published by GlobeNewswire Clinical Studies on September 28, 2026 12:00 PM

Read Original